Date: February 23, 2022
Time: 09:00am (PST), 12:00pm (EST)
During this webinar we will present the Lahey four-year journey of using the MBT Sepsityper® solution for the rapid identification (ID) of microorganisms direct from positive blood culture (PBC). The focus will be on the recent implementation of the MBT Sepsityper Kit US IVD, the only FDA cleared MALDI-TOF based application available for rapid ID direct from PBC, in the clinical microbiology laboratory at Lahey Hospital and Medical Center. The presentation will discuss 1) the ease and benefits of implementing an FDA-cleared application, 2) how the MBT Sepsityper® workflow can be used as a rapid front-line method to identify a broad range of microorganisms, 3) how to decrease the use of expensive molecular applications on the blood culture bench with workflow suggestions, and 4) present actual case studies that demonstrate the clinical impact of a rapid ID direct from PBC using MBT Sepsityper® workflow. Finally in closing, please join the Q & A session where you can ask Felicia, a proven MBT Sepsityper expert, questions that you may have.
- List (3) benefits of implementing an FDA-cleared application vs a laboratory developed test (LDT) in a US clinical microbiology laboratory.
- Discuss how the MALDI-TOF based application for rapid ID direct from PBC can be used as a front-line method and how this approach can directly impact patient or institutional outcomes.
- Describe how the MBT Sepsityper® result can directly influence the treatment path of a patient, especially when the MBT Sepsityper® ID result is reported with the Gram stain result.
- Discuss how significant cost savings can be realized when MALDI-TOF and Molecular workflows are combined.
Only for sale in the United States and Puerto Rico.
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.